Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Hannelore Ceuppens

Vrije Universiteit Brussel

Belgium

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Academic Page

Research Interests

Immunology

70%

Biochemistry

20%

Antibodies

50%

Immunotherapy

50%

Radiopharmaceutical Chemistry

40%

Nanomedicine

20%

Tumor Immunology

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles11

Efficient α and β- radionuclide therapy targeting fibroblast activation protein-α in an aggressive preclinical mouse tumour model

Article Link

Year:

2025

Immune modulation following α and β − radionuclide therapy targeting fibroblast activation protein-α in a preclinical tumor model

Article Link

Year:

2025

Generic semi-automated radiofluorination strategy for single domain antibodies: [18F]FB-labelled single domain antibodies for PET imaging of fibroblast activation protein-α or folate receptor-α overexpression in cancer

Article Link

Year:

2024

Development and evaluation of a single domain antibody targeting folate receptor alpha for radioligand therapy

Article Link

Year:

2024

Targeted α-Therapy Using 225Ac Radiolabeled Single-Domain Antibodies Induces Antigen-Specific Immune Responses and Instills Immunomodulation Both Systemically and at the Tumor Microenvironment

Article Link

Year:

2023

In vitro modelling of local gene therapy with IL-15/IL-15Rα and a PD-L1 antagonist in melanoma reveals an interplay between NK cells and CD4+ T cells

Article Link

Year:

2023

Development and evaluation of nanobody tracers for noninvasive nuclear imaging of the immune-checkpoint TIGIT

Article Link

Year:

2023

Targeted radionuclide therapy with low and high-dose Lutetium-177 labeled single domain antibodies induces distinct immune signatures in a mouse melanoma model

Article Link

Year:

2022

Emerging applications of nanobodies in cancer therapy

Article Link

Year:

2022

Novel 3D Lung Tumor Spheroids for Oncoimmunological Assays

Article Link

Year:

2022

Formatting and gene-based delivery of a human PD-L1 single domain antibody for immune checkpoint blockade

Article Link

Year:

2021

Collaborators26

Sophie Hernot

Vrije Universiteit Brussel

BELGIUM

Katty Zeven

Vrije Universiteit Brussel

BELGIUM

Heleen Hanssens

Vrije Universiteit Brussel

BELGIUM

Wout De Mey

Vrije Universiteit Brussel

BELGIUM

Kirsten De Ridder

Vrije Universiteit Brussel

BELGIUM

Cleo Goyvaerts

Vrije Universiteit Brussel

BELGIUM

Yannick De Vlaeminck

Vrije Universiteit Brussel

BELGIUM

Geert Raes

Vrije Universiteit Brussel

BELGIUM

Vicky Caveliers

Vrije Universiteit Brussel

BELGIUM

Jessica Bridoux

Vrije Universiteit Brussel

BELGIUM

Robin Maximilian Awad

Vrije Universiteit Brussel

BELGIUM

Ahmet Krasniqi

Vrije Universiteit Brussel

BELGIUM

Lien De Beck

Vrije Universiteit Brussel

BELGIUM

Matthias D'Huyvetter

Vrije Universiteit Brussel

BELGIUM

HANNE LOCY

Vrije Universiteit Brussel

BELGIUM

Magali Verdonck

Vrije Universiteit Brussel

BELGIUM

Janik Puttemans

Vrije Universiteit Brussel

BELGIUM

Lukasz Mateusiak

Vrije Universiteit Brussel

BELGIUM

Quentin Lecocq

Vrije Universiteit Brussel

BELGIUM

Herlinde Dierick

Vrije Universiteit Brussel

BELGIUM

Kim De Veirman

Vrije Universiteit Brussel

BELGIUM

Fien Meeus

Vrije Universiteit Brussel

BELGIUM

Thomas Ertveldt

Vrije Universiteit Brussel

BELGIUM

Ana Rita Pombo Antunes

Vrije Universiteit Brussel

BELGIUM

Timo De Groof

Vrije Universiteit Brussel

BELGIUM

Nick Devoogdt

Vrije Universiteit Brussel

BELGIUM

How do I reach out?

Meet Kite AI